Medical Oncology

Prof. Dr. Bülent Karagöz

Doctor and researcher Anadolu Sağlık Merkezi Hastanesi Kocaeli

Medical Oncology. The branch of medicine that looks after cancers, illnesses in which cells of the body multiply out of control and form tumours.

Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: anadolusaglik.org.

  • Onkoloji Merkezi (Kanser Merkezi)
  • Kemoterapi
  • Tümör Biyolojisi
  • Tümör İmmünolojisi
  • Kanserin İmmün Tedavisi
  • Hedefe Yönelik Tedaviler

CV

Education and experience

From source

2019 yılından bu yana, Özel Anadolu Sağlık Merkezi’nde Onkoloji Uzmanı olarak görevini sürdürüyor.

Experience

  • ExperienceÇorlu Asker Hastanesianadolusaglik.org
  • ExperienceKosova KFOR Komutanlığı (NATO bünyesinde)anadolusaglik.org
  • ExperienceGATA Haydarpaşa Eğitim Hastanesianadolusaglik.org
  • Experienceİstanbul Okan Üniversitesianadolusaglik.org

Education

  • EducationGülhane Askeri Tıp Akademisi Tıp Fakültesi, 1986-1992.anadolusaglik.org
  • EducationGATA Haydarpaşa Eğitim Hastanesi, İç Hastalıkları Uzmanlık eğitimi, 1995-1999.anadolusaglik.org
  • EducationGATA Haydarpaşa Eğitim Hastanesi, Tıbbi Onkoloji Yandal Uzmanlık eğitimi, 2003-2006.anadolusaglik.org

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologyanadolusaglik.orgFrom source
  • Department name in the sourceMedikal Onkolojianadolusaglik.orgFrom source
  • InstitutionAnadolu Sağlık Merkezi Hastanesianadolusaglik.orgFrom source
  • Publications43 publicationsanadolusaglik.org profile pageFrom source
  • Last synchronised11 November 2026 22:58https://www.anadolusaglik.org/doktor/bulent-karagozanadolusaglik.org

Scientific work

Publications

43 publications

  1. Kandemir, E. G., A. Mayadagli, B. Karagöz, O. Bilgi, O. Turken ve M.Yaylacı, “Prognostic Significance of Thrombocytosis in Node-negative Colon Cancer,” J Int Med Res, 33 (2), 228-235 (2005).

    Source: anadolusaglik.org profile page

  2. Karagöz, B., S. Süleymanoğlu, G. Uzun, O. Bilgi, S. Aydınöz, A. Haholu, O. Türken, Y. Önem ve E. G. Kandemir, “Hyperbaric Oxygen Therapy Does Not Potentiate Doxorubicin-induced Cardiotoxicity in Rats,” Basic Clin Pharmacol Toxicol, 102 (3), 287-292 (2008).

    Source: anadolusaglik.org profile page

  3. Bilgi, O., B. Karagöz, O. Turken, E. G. Kandemir, A. Ozturk, M. Gumus ve M. Yaylacı, “Peripheral Blood Gamma-Delta T Cells in Advanced-Stage Cancer Patients,” Adv Ther, 25 (3), 218-224 (2008).

    Source: anadolusaglik.org profile page

  4. Erikçi, A. A., A. Öztürk, B. Karagöz, O. Bilgi, O. Türken, C. Top ve E. G. Kandemir, “Results of Combination Therapy With Amifostine, Pentoxifylline, Ciprofloxacin And Dexamethasone in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia,” Hematology, 13 (5), 289-292 (2008).

    Source: anadolusaglik.org profile page

  5. Aydinoz, S., G. Uzun, H. Cermik, E. M. Atasoyu, Ş. Yıldız, B. Karagoz ve R. Evrenkaya, “Effect of Different Doses of Hyperbaric Oxygen on Cisplatin-Induced Nephrotoxicity,” Ren Fail, 29 (3), 1-7 (2007).

    Source: anadolusaglik.org profile page

  6. Erikçi, A. A., B. Karagöz, A. Öztürk, S. Çağlayan, G. Özışık, i. Kaygusuz ve M. Özata, “The Effect of Subclinical Hypothyroidism on Platelet Parameters,” Hematology, 14 (2), 115-117 (2009).

    Source: anadolusaglik.org profile page

  7. Karagöz, B., O. Bilgi, M. Gümüs, A. A. Erikçi, Ö. Sayan, O. Türken, E. G. Kandemir, A. Oztürk ve M. Yaylacı, “CD8+CD28- Cells and CD4+CD25+ Regulatory T cells in The Peripheral Blood of Advanced Stage Lung Cancer Patients,” Med Oncol, 27 (1), 29-33 (2010).

    Source: anadolusaglik.org profile page

  8. Erikçi, A. A., B. Karagöz, M. Özyurt, A. Ozturk, S. Kılıç ve O. Bilgi, “HLA-G Expression in B Chronic Lymphocytic Leukemia: A New Prognostic Marker?” Hematology, 14 (2), 101-105 (2009).

    Source: anadolusaglik.org profile page

  9. Karagöz, B., O. Bilgi, E. G. Kandemir, Ö. Sayan, A. A. Erikçi, A. Özgün, B. Yılmaz ve A. Öztürk, “Decreased NKG2D Expression on Natural Killer Cells in Gastric Cancer Patients”, UHOD, 19 (1), 42-47 (2009).

    Source: anadolusaglik.org profile page

  10. Karagöz, B., O. Bilgi, A. Alacacıoğlu, A. Özgün, Ö Sayan, A. A. Erikçi ve E. G. Kandemir, “Mean Platelet Volume Increase after Tamoxıfen, but not after Anastrazole in Adjuvant Therapy of Breast Cancer,” Med Oncol, 27 (2),199-202 (2010).

    Source: anadolusaglik.org profile page

View all 43 publications